Dr. Praveena Manogaran is Head of Applications at MaxWell Biosystems, where she works at the interface of neuroscience, technology, and product development, advancing electrophysiology-based approaches for in vitro disease modeling, phenotyping, and pharmacology. She leads the Products and Applications team, driving product commercialization and scientific applications for HD-MEA electrophysiology platforms. With a background spanning clinical research, preclinical drug discovery, and advanced in vitro systems, her work centers on translating complex neural signals into meaningful, quantitative readouts. She completed her PhD in Neuroscience at ETH Zurich and a postdoctoral fellowship at F. Hoffmann-La Roche, focusing on neuroprotection and model development in neurodegenerative disease and ophthalmology.

Outside of work, she enjoys rock and ice climbing, crocheting, entomology, and playing Dungeons & Dragons.

‍

‍